Coming Soon
Understanding Allergy to Codeine (Codeine Hypersensitivity, Codeine Intolerance) is crucial for accurate clinical documentation and medical coding. This resource provides information on diagnosing and managing Codeine Allergy, including symptoms, testing, and treatment options. Learn about proper healthcare protocols and coding guidelines related to Codeine Hypersensitivity for improved patient care and accurate medical records.
Also known as
Allergy to narcotic analgesics
Adverse effect of codeine, unspecified
Allergy status to drugs, medicaments and biological substances
Personal history of allergy to drugs and medicines
Other adverse effects, not elsewhere classified
Adverse effect of unspecified drug, medicinal and biological substance
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the allergy to codeine confirmed?
When to use each related code
| Description |
|---|
| Allergic reaction to codeine. |
| Non-allergic adverse reaction to codeine. |
| Opioid-induced respiratory depression. |
Incorrect code assignment due to confusion between allergy, intolerance, and adverse reactions. Impacts reimbursement and patient safety.
Using unspecified allergy codes when a more specific code (e.g., T78.40XA) is applicable. Leads to data inaccuracy and claim denials.
Missing or insufficient documentation of codeine allergy details (reaction, onset). Creates audit risks and hinders appropriate care management.
Q: How can I differentiate between a true allergy to codeine and pseudoallergic reactions in my clinical practice?
A: Differentiating a true codeine allergy (immunoglobulin E-mediated reaction) from a pseudoallergic reaction (non-immunologic histamine release) requires careful clinical evaluation. True allergies to codeine present with classic allergic symptoms like hives, angioedema, or anaphylaxis, often occurring shortly after exposure. Pseudoallergic reactions, however, manifest similarly with itching and flushing, but usually lack respiratory symptoms. They are triggered by codeine's direct mast cell activation and histamine release, not by IgE antibodies. A detailed patient history, including symptom onset, duration, and associated factors, is essential. Skin testing can be helpful in confirming IgE-mediated allergy in some cases. Consider implementing a structured allergy assessment protocol in your practice to improve diagnostic accuracy. Explore how pharmacogenomic testing may help identify patients at risk for adverse reactions to codeine.
Q: What are the recommended alternative analgesics for patients with confirmed codeine allergy or codeine hypersensitivity?
A: Patients with confirmed codeine allergy or hypersensitivity require alternative analgesic strategies. Avoid all opioids metabolized to morphine, such as hydrocodone, oxycodone, and tramadol, as these can trigger cross-reactivity due to their shared metabolic pathway. Non-opioid analgesics like NSAIDs (ibuprofen, naproxen) or acetaminophen can be effective for mild to moderate pain. For more severe pain, consider non-opioid alternatives such as gabapentinoids (gabapentin, pregabalin) or selective norepinephrine reuptake inhibitors (SNRIs) like duloxetine or venlafaxine. Local anesthetics, regional nerve blocks, and other non-pharmacological pain management techniques may also be appropriate depending on the clinical context. Learn more about multimodal pain management strategies to personalize treatment for patients with codeine allergies.
Patient presents with symptoms suggestive of codeine allergy, including codeine hypersensitivity or codeine intolerance. The patient reports experiencing adverse reactions after codeine administration. These reactions may include urticaria, pruritus, angioedema, respiratory distress, nausea, vomiting, or hypotension following recent codeine exposure. The onset of symptoms occurred within minutes to hours after taking codeine-containing medication. Differential diagnoses considered include opioid-induced histamine release, other drug allergies, and non-allergic adverse drug reactions. A thorough medication history was reviewed, including over-the-counter medications, supplements, and herbal remedies, to identify potential drug interactions or contributing factors. Family history of allergies and adverse drug reactions was also assessed. Diagnosis of codeine allergy is based on clinical presentation, patient history, and temporal relationship between codeine ingestion and symptom onset. Skin testing or challenge testing may be considered for confirmation if clinically appropriate and safe. Patient education provided regarding avoidance of codeine and codeine-containing medications. Alternative analgesics recommended for pain management, excluding opioids with cross-reactivity potential. The patient was advised to carry medical identification indicating codeine allergy. ICD-10-CM code T78.40XA (Allergy, unspecified, initial encounter) and appropriate SNOMED CT codes are being considered for documentation and billing purposes. Follow-up scheduled to monitor patient response and address any further concerns. The importance of alerting all healthcare providers to this allergy was emphasized.